Patterns of antibody binding to aquaporin-4 isoforms in neuromyelitis optica

PLoS ONE

Volumn 5, Issue 5, 2010, Pages

  Mader, Simone ^a   Lutterotti, Andreas ^a   Di Pauli, Franziska ^a   Kuenz, Bettina ^a   Schanda, Kathrin ^a   Aboul Enein, Fahmy ^b   Khalil, Michael ^c   Storch, Maria K ^c   Jarius, Sven ^d   Kristoferitsch, Wolfgang ^b   Berger, Thomas ^a   Reindl, Markus ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b SMZ Ost Donauspital ^*  (Austria)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN 4; BIOLOGICAL MARKER; EPITOPE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; ISOPROTEIN; PROTEIN ANTIBODY;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIGEN BINDING; ANTIGEN SPECIFICITY; ARTICLE; BLOOD SAMPLING; CELL STRAIN HEK293; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HIGH RISK PATIENT; HUMAN; IMMUNOFLUORESCENCE TEST; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NEUROLOGIC DISEASE; RELAPSE; SENSITIVITY AND SPECIFICITY; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AQUAPORIN 4; CELL LINE; FEMALE; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; NEUROMYELITIS OPTICA; PROTEIN ISOFORMS; RISK FACTORS; STAINING AND LABELING; TRANSFECTION; YOUNG ADULT;

EID: 77956408502     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0010455     Document Type: Article

References (31)

1. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG (1999) The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 53: 1107-1114.
2. Cree B (2008) Neuromyelitis optica: diagnosis, pathogenesis, and treatment. Curr Neurol Neurosci Rep 8: 427-433.
3. Wingerchuk DM, Weinshenker BG (2003) Neuromyelitis optica: clinical predictors of a relapsing course and survival. Neurology 60: 848-853.
4. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, et al. (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364: 2106-2112.
5. Jarius S, Franciotta D, Bergamaschi R, Wright H, Littleton E, et al. (2007) NMO-IgG in the diagnosis of neuromyelitis optica. Neurology 68: 1076-1077.
6. Weinshenker BG (2007) Neuromyelitis optica is distinct from multiple sclerosis. Arch Neurol 64: 899-901.
7. Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, et al. (2007) Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 130: 1194-1205.
8. Misu T, Fujihara K, Kakita A, Konno H, Nakamura M, et al. (2007) Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain 130: 1224-1234.
9. Jarius S, Paul F, Franciotta D, Waters P, Zipp F, et al. (2008) Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica. Nat Clin Pract Neurol 4: 202-214.
10. Wingerchuk DM (2007) Diagnosis and treatment of neuromyelitis optica. Neurologist 13: 2-11.
11. Cree BA, Lamb S, Morgan K, Chen A, Waubant E, et al. (2005) An open label study of the effects of rituximab in neuromyelitis optica. Neurology 64: 1270-1272.
12. Keegan M, Pineda AA, McClelland RL, Darby CH, Rodriguez M, et al. (2002) Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology 58: 143-146.
13. Jacob A, Weinshenker BG, Violich I, McLinskey N, Krupp L, et al. (2008) Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients. Arch Neurol 65: 1443-1448.
14. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66: 1485-1489.
15. Weinshenker BG, Wingerchuk DM, Vukusic S, Linbo L, Pittock SJ, et al. (2006) Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol 59: 566-569.
16. Pittock SJ, Lennon VA, de Seze J, Vermersch P, Homburger HA, et al. (2008) Neuromyelitis optica and non organ-specific autoimmunity. Arch Neurol 65: 78-83.
17. Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR (2005) IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202: 473-477.
18. Satoh J, Tabunoki H, Yamamura T, Arima K, Konno H (2007) Human astrocytes express aquaporin-1 and aquaporin-4 in vitro and in vivo. Neuropathology 27: 245-256.
19. Neely JD, Christensen BM, Nielsen S, Agre P (1999) Heterotetrameric composition of aquaporin-4 water channels. Biochemistry 38: 11156-11163.
20. Furman CS, Gorelick-Feldman DA, Davidson KG, Yasumura T, Neely JD, et al. (2003) Aquaporin-4 square array assembly: opposing actions of M1 and M23 isoforms. Proc Natl Acad Sci U S A 100: 13609-13614.
21. Jung JS, Bhat RV, Preston GM, Guggino WB, Baraban JM, et al. (1994) Molecular characterization of an aquaporin cDNA from brain: candidate osmoreceptor and regulator of water balance. Proc Natl Acad Sci U S A 91: 13052-13056.
22. Nicchia GP, Mastrototaro M, Rossi A, Pisani F, Tortorella C, et al. (2009) Aquaporin-4 orthogonal arrays of particles are the target for neuromyelitis optica autoantibodies. Glia 57: 1363-1373.
23. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, et al. (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 58: 840-846.
24. Takahashi T, Fujihara K, Nakashima I, Misu T, Miyazawa I, et al. (2007) Antiaquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain 130: 1235-1243.
25. Bradl M, Misu T, Takahashi T, Watanabe M, Mader S, et al. (2009) Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo. Ann Neurol 66: 630-643.
26. Takahashi T, Fujihara K, Nakashima I, Misu T, Miyazawa I, et al. (2006) Establishment of a new sensitive assay for anti-human aquaporin-4 antibody in neuromyelitis optica. Tohoku J Exp Med 210: 307-313.
27. Waters P, Vincent A (2008) Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: current status of the assays. Int MS J 15: 99-105.
28. Crane JM, Tajima M, Verkman AS (2009) Live-cell imaging of aquaporin-4 diffusion and interactions in orthogonal arrays of particles. Neuroscience.
29. Jarius S, Aboul-Enein F, Waters P, Kuenz B, Hauser A, et al. (2008) Antibody to aquaporin-4 in the long-term course of neuromyelitis optica. Brain 131: 3072-3080.
30. Graber DJ, Levy M, Kerr D, Wade WF (2008) Neuromyelitis optica pathogenesis and aquaporin 4. J Neuroinflammation 5: 22.
31. Elkon K, Casali P (2008) Nature and functions of autoantibodies. Nat Clin Pract Rheumatol 4: 491-498.